Safety and Efficacy of Ad-p53 in Head and Neck Cancer

Condition:   Recurrent Head and Neck Cancer
Interventions:   Drug: Ad-P53;   Drug: Opdivo
Sponsor:   MultiVir, Inc.
Recruiting

https://ift.tt/2LVDENv